Company
United StatesRegenerative Biologics, Birmingham, AL – FDA Inspections
Inspection records and compliance data for Regenerative Biologics in Birmingham, Alabama. 2 FDA inspections on record, last inspected April 24, 2026.
Company Profile
This profile covers Regenerative Biologics based in Birmingham, Alabama, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected April 27, 2018. Last inspected April 24, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 24, 2026 | NAI | · Human Cellular, Tissue, and Gene Therapies | 1315396 |
| April 27, 2018 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1056313 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Regenerative Biologics
FEI Number
3013545785
Address
300 Cahaba Park Cir Ste 214, Birmingham, Alabama 35242, United States
Country
United States
ID: 220d9327-9c52-4c37-8ecb-2c85656d9bfb